Pfizer Hit With $1.3B Fine For Bextra Marketing

Law360, New York (October 16, 2009, 7:15 PM EDT) -- A federal court has levied a record $1.3 billion criminal fine — the largest ever imposed in the U.S. — against Pfizer Inc. subsidiary Pharmacia & Upjohn Co. Inc. for fraudulently misbranding its anti-inflammatory drug Bextra.

Judge Douglas Woodlock of the U.S. District Court for the District of Massachusetts sentenced Pharmacia to pay a criminal fine of $1.195 billion and a criminal forfeiture of $105 million, a total of $1.3 billion, at a hearing Friday.

The U.S. Attorney’s Office of Massachusetts, which prosecuted the case on...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.